These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34633594)

  • 21. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
    Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HCG11 Accelerates Atherosclerosis via Regulating the miR-224-3p/JAK1 Axis.
    Zhou H; Song WH
    Biochem Genet; 2023 Feb; 61(1):372-389. PubMed ID: 35931919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.
    Yi B; Li H; Cai H; Lou X; Yu M; Li Z
    J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.
    Kang H; Yu H; Zeng L; Ma H; Cao G
    Hypertens Res; 2022 Jun; 45(6):976-989. PubMed ID: 35264782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LOXL1-AS1 Aggravates Myocardial Ischemia/Reperfusion Injury Through the miR-761/PTEN Axis.
    He W; Duan L; Zhang L
    Korean Circ J; 2023 Jun; 53(6):387-403. PubMed ID: 37161797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and mechanism of circular RNA circ_0050486 in regulating oxidized low-density lipoprotein-induced injury in endothelial cells.
    Zhang P; Wang W; Li M
    Clin Hemorheol Microcirc; 2022; 82(2):107-124. PubMed ID: 35723090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-derived extracellular vesicles encapsulate microRNA-34c-5p to ameliorate inflammatory response of coronary artery endothelial cells via PODXL-mediated P38 MAPK signaling pathway.
    Bai X; Zhang H; Li Z; Chen O; He H; Jia X; Zou L
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2424-2438. PubMed ID: 36096977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma.
    Feng Z; Ye Z; Xie J; Chen W; Li W; Xing C
    Biol Direct; 2021 Dec; 16(1):24. PubMed ID: 34863279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p /LYPLA1 Axis.
    Zhang Y; Zheng M; Zhang L; Yuan P; Zhou J; Wang Y; Wang H
    Biochem Genet; 2022 Aug; 60(4):1298-1312. PubMed ID: 34984578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Zhang P; Zhao F; Jia K; Liu X
    Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway.
    Li S; Sun Y; Zhong L; Xiao Z; Yang M; Chen M; Wang C; Xie X; Chen X
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1175-1187. PubMed ID: 30314869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis.
    Zhang L; Xie H; Li S
    J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular vesicle-mediated transfer of lncRNA CLDN10-AS1 aggravates low-density lipoprotein-induced vascular endothelial injury.
    Fu X; Liu H; Fan Y; Yuan J
    Physiol Genomics; 2022 Dec; 54(12):471-485. PubMed ID: 36250558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of LINC00657 inhibits ox-LDL-induced endothelial cell injury by regulating miR-30c-5p/Wnt7b/β-catenin.
    Wu H; Liu T; Hou H
    Mol Cell Biochem; 2020 Sep; 472(1-2):145-155. PubMed ID: 32577947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of lncRNA H19 alleviates ox-LDL-induced HCAECs inflammation and injury by mediating miR-20a-5p/HDAC4 axis.
    Yang Y; Wang Z; Xu Y; Liu X; Sun Y; Li W
    Inflamm Res; 2022 Sep; 71(9):1109-1121. PubMed ID: 35854140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis.
    Guo JT; Wang L; Yu HB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9633-9644. PubMed ID: 33015807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.